This presentation contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on our management's beliefs and assumptions and on information currently available to our management. Forward-looking statements include the following factors in reference to Clearwater (including its recently completed acquisitions), our possible or assumed future results of operations, possible or assume ...

Clearwater Analytics (CWAN) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.10 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 8.33%. A quarter ago, it was expected that this automated investment accounting software developer would post earnings of $0.11 per share when it actually produced earnings of $0.13, delivering a surprise of 1 ...

Financial Data and Key Metrics Changes - Revenue for Q1 2025 was $126.9 million, representing a year-on-year growth of 23.5% [4][29] - Annualized recurring revenue (ARR) reached $493.9 million, up 22.7% year-on-year [5][30] - Adjusted EBITDA was $45.1 million, accounting for 35.5% of revenue, with a year-on-year growth of 40% [5][31] - Gross margin improved to 78.9%, up from 75.1% in FY 2022, exceeding expectations [13][30] Business Line Data and Key Metrics Changes - The company has maintained over 20% revenue growth for the past six years, with a win rate of 80% and a gross revenue retention rate (GRR) of over 98% [9][10] - The launch of a commercial contract restructuring program in 2022 has helped dampen revenue downside during AUM declines while retaining revenue upside during AUM growth [10] Market Data and Key Metrics Changes - The company has secured significant wins in Europe, including a leading German insurance company, which validates its expansion strategy [18] - A global asset manager expanded its partnership to include additional solutions, demonstrating strong cross-sell momentum [18] Company Strategy and Development Direction - The strategic acquisitions of Infusion, Beacon, and Bistro aim to create a fully cloud-native investment platform that integrates front, middle, and back office operations [19][20] - The company plans to implement a three-phase roadmap focusing on maximizing standalone business potential, cross-selling, and developing a unified platform [23][25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to execute and drive growth despite market complexities [5][16] - The company is focused on client satisfaction and operational efficiency, which are seen as key to improving profitability [12][31] Other Important Information - The company expects to achieve a 20% growth rate, with a 50 basis point gross margin improvement and a 200 basis point EBITDA expansion per year [27] - The integration of operations and client servicing teams under common leadership is expected to enhance efficiency [14] Q&A Session Summary Question: Thoughts on future growth rates and margin pacing - Management reiterated a commitment to 20% growth for Clearwater and Beacon, with expectations for Infusion to improve from 13% growth [46][47] Question: Demand outlook and macroeconomic impact - Management noted that Q1 revenue was solid and that they have not seen significant negative impacts from recent market turmoil [58][60] Question: Synergies from acquisitions - Management confirmed expectations for $20 million in cost synergies and improvements in gross margin over the next two years [66] Question: Organic growth expectations - Management provided guidance indicating that organic growth for Clearwater would remain above 20%, with contributions from acquisitions factored in [84][87] Question: Insights on Infusion's pricing and customer conversations - Management indicated a strong receptivity to developing a stable commercial model for Infusion, aiming for consistent growth [79][80]

Clearwater Analytics Announces First Quarter 2025 Financial Results Record Quarterly Revenue of $126.9 Million, Up 24% Year-Over-Year Annualized Recurring Revenue of $493.9 Million, Up 23% Year-Over-Year Gross Revenue Retention Rate of 98%; Net Revenue Retention Rate of 114% Net Income of $6.9 Million Adjusted EBITDA of $45.1 Million, Up 40% Year-Over-Year BOISE, Idaho — April 30, 2025 — Clearwater Analytics Holdings, Inc. (NYSE: CWAN) ("Clearwater Analytics" or the "Company"), the most comprehensive techno ...

Financial Performance - Total revenue for 2024 reached $451.8 million, a 22.7% increase from $368.2 million in 2023[360]. - Gross profit for 2024 was $328.8 million, up 25.9% from $261.0 million in 2023[360]. - Net income for 2024 was $427.6 million, compared to a net loss of $23.1 million in 2023[360]. - Comprehensive income for 2024 was $423.1 million, compared to a loss of $20.3 million in 2023[362]. - Basic net earnings per share for 2024 were $1.93, a recovery from a loss of $0.11 per share in 2023[360]. - Employee compensation expense increased to $208.4 million in 2024, up from $184.7 million in 2023, reflecting a 12.7% rise[492]. - Consolidated net income for 2024 was $427.6 million, a significant recovery from a net loss of $23.1 million in 2023[492]. Assets and Liabilities - As of December 31, 2024, the total assets loaded on the platform reached $8.8 trillion, up from $7.3 trillion in 2023, indicating a significant growth in asset management[19]. - Total assets as of December 31, 2024, were $1.17 billion, significantly up from $558.7 million in 2023[358]. - The company reported a debt balance of $46.1 million under the Credit Agreement, with a potential interest expense fluctuation of approximately $0.2 million for a hypothetical 100 basis points change in the Secured Overnight Financing Rate (SOFR)[332]. - The company’s net carrying amount of debt as of December 31, 2024, was $45.914 million, with future maturities of $2.750 million due in 2025 and $43.313 million in 2026[460]. - Total stockholders' equity attributable to Clearwater Analytics Holdings, Inc. increased to $1.01 billion in 2024, compared to $354.3 million in 2023[358]. Tax and Deferred Assets - Deferred tax assets related to the investment in partnership amounted to $514 million as of December 31, 2024, reflecting the company's strategic financial positioning[344]. - The company reported a total of $625.1 million in deferred tax assets as of December 31, 2024, compared to $512.9 million in 2023[499]. - The valuation allowance decreased by $493 million during 2024, primarily due to the release of the valuation allowance on most U.S. federal and state deferred tax assets[501]. - The effective tax rate for 2024 was 1,522.3%, significantly impacted by the release of the majority of the valuation allowance on U.S. deferred tax assets[497]. Revenue Recognition and Deferred Revenue - The Company recognizes revenue from professional services on a time and materials basis as services are delivered[392]. - Deferred revenue consists of non-refundable fees invoiced during the period in which the Company is performing set-up activities for the SaaS solution[397]. - The company’s deferred revenue increased significantly to $7.329 million in 2024 from $2.766 million in 2023, marking a growth of about 164.5%[453]. - For the year ended December 31, 2024, $2.4 million of total revenue was included in the deferred revenue balance as of December 31, 2023, related to the company's SaaS solution[439]. Acquisitions and Growth - The company completed the acquisition of Wilshire Technology for a total purchase consideration of $40.1 million in cash on April 22, 2024, which includes goodwill of $28.24 million attributed to expected post-acquisition synergies[443][445]. - The company entered into a merger agreement to acquire Enfusion, Inc. for approximately $1.5 billion, expected to close in Q2 2025, subject to shareholder and regulatory approvals[517][518]. - A senior secured term loan B facility of $800 million was completed to finance part of the cash consideration for the Enfusion acquisition, with an interest rate based on SOFR plus 2.25%[519]. Operational Challenges - The company faces prolonged sales cycles and substantial upfront sales costs when targeting large financial institutions, which may affect revenue predictability[16]. - The company relies heavily on fees based on the value of assets on its platform, making it vulnerable to market volatility and economic downturns[16]. - Rising inflation has impacted operations in India, although it has not materially affected the overall business performance as of now[333]. Internal Controls and Audit Matters - The company maintains effective internal control over financial reporting as of December 31, 2024, according to the independent auditor's opinion[351]. - The evaluation of deferred tax assets is considered a critical audit matter, requiring complex judgment and specialized knowledge[345]. Stock and Equity - The company issued 291,266 shares under the Employee Stock Purchase Plan (ESPP), generating $4,693,000 in additional capital[365]. - The total paid-in capital increased to $725,174,000 as of December 31, 2024, up from $532,507,000 in 2023[365]. - The total number of shares outstanding as of December 31, 2023, was 212,857,580, reflecting significant growth from the previous year[365]. - The Company granted 4.1 million RSUs in 2024, with a weighted average grant date fair value of $20.02[477]. Research and Development - Research and development expenses increased to $150.6 million in 2024, a 21.5% rise from $123.9 million in 2023[360]. - Research and development costs consist of personnel expenses, including salaries and benefits, for employees engaged in the design and development of the Company's offerings[415].

Following my coverage on Clearwater Analytics Holdings (NYSE: CWAN ) in December, which I recommended a buy rating due to my expectation that growth can continue to accelerate back to mid-20%, which will support valuation to stay >13x forwardI take a fundamentals-based approach to value investing.I disagree with the common misconception held by many investors that low multiple stocks must be cheap. I look for companies that offer the best long-term durability at the most affordable prices. Consequently, I h ...

Clearwater Analytics (CWAN) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.10 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 18.18%. A quarter ago, it was expected that this automated investment accounting software developer would post earnings of $0.11 per share when it actually produced earnings of $0.12, delivering a surprise of ...

Exhibit 99.1 Clearwater Analytics Announces Fourth Quarter and Full Year 2024 Financial Results Record Quarterly Revenue of $126.5 Million, Up 28% Year-Over-Year Annualized Recurring Revenue of $474.9 Million, Up 25% Year-Over-Year Net Revenue Retention Rate of 116% Net Income of $420.3 Million Adjusted EBITDA of $41.7 Million, Up 39% Year-Over-Year BOISE, Idaho — February 19, 2025 — Clearwater Analytics Holdings, Inc. (NYSE: CWAN) ("Clearwater Analytics" or the "Company"), a leading worldwide provider of S ...

Clearwater Analytics (CWAN) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a ch ...

Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, January 3rd:Surmodics, Inc. (SRDX) : This company that provides performance coating technologies for the medical sector has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.8% over the last 60 days.Surmodics’ shares gained 3.3% over the last three months compared with the S&P 500’s advance of 2.3%. The company possesses a Momentum Score  of A.Clearwater ...